David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

Australia has the cheapest rosacea treatments in the world!

Australia has the cheapest rosacea treatments in the world!

Being a rosacea sufferer in Australia can be a depressing experience. It seems that the rest of the English speaking world get all the latest and greatest treatments years before we do here downunder. New treatments can take years to be approved in Australia. We Ozzies suffer from a bit of an insecurity complex because […]

Continue Reading

Finacea vs. Metrogel and Mirvaso–Fight!

Finacea vs. Metrogel and Mirvaso–Fight!

A recently listed Clinical Trial aims to recruit rosacea sufferers to find out how well they are getting on with their usage of Finacea, Metrogel and Mirvaso. The trial outcomes are several, but include the recording of adverse reactions to treatments, patient satisfaction and likelihood of switching rosacea treatment. The trial is being sponsored by […]

Continue Reading

Pregabalin (Lyrica) for Neurogenic Rosacea

Written by on November 20, 2015 in neurogenic rosacea with 1 Comment
Pregabalin (Lyrica) for Neurogenic Rosacea

The correspondence section in December’s edition of Clinical and Experimental Dermatology has a brief note from 3 doctors from the UK who describe a 61 year old sufferer of neurogenic rosacea. This patient was successfully treated with Pregabalin (Lyrica). Pregabalin is listed as one of the possible treatments for neurogenic rosacea. The authors suggest that […]

Continue Reading

Its official–Mirvaso, Soolantra and Oracea make the grade as proven rosacea treatments

Its official–Mirvaso, Soolantra and Oracea make the grade as proven rosacea treatments

The just published update to the 2011 Cochrane review of interventions for rosacea has given its opinion on the last 4 years of published rosacea research. Previous Cochrane reviews on rosacea interventions have been published in 2004, 2005 and 2011. This review looked at 106 randomized clinical trials with 13,631 participants. Cochrane Review Results The […]

Continue Reading

Mirvaso is not for every red-faced rosacea sufferer

Written by on November 18, 2015 in Mirvaso Gel (Brimonidine 0.33%) with 1 Comment

A really interesting paragraph from Dr. Powell in the September 2015 BJD. Understanding rosacea, Powell F.C., British Journal of Dermatology (2015) 173, pp635–640 Brimonidine tartrate gel 0.5%, a topical alpha 2 adrenergic agonist with vasoconstrictor properties, was shown to be effective in reducing moderate to severe erythema in patients with rosacea, a major benefit for […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.